Use of thrombolysis in acute ischaemic stroke

Emergency Medicine Journal

Volumn 27, Issue 3, 2010, Pages 245-248

  Ferguson, Craig ^a   Choudhury, Monojit ^b  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b Stirling Royal Infirmary   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO; UROKINASE; FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; HUMAN; MORTALITY; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; BRAIN ISCHEMIA; CASE REPORT; EMERGENCY HEALTH SERVICE; EVIDENCE BASED EMERGENCY MEDICINE; FEMALE; MIDDLE AGED; REVIEW; STROKE;

BRAIN ISCHEMIA; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED EMERGENCY MEDICINE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; STROKE;

EID: 77949879131     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2009.089656c     Document Type: Note

References (6)

1. Wardlaw JM, del Zoppo GJ, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:3. CD000213.
2. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-9.
3. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
4. Hacke W, Kaste M, Bluhmki E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
6. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.